Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck
Robert L. Ferris, Kevin J. Harrington, Jonathan D. Schoenfeld, et al.
Cancer Treatment Reviews (2022) Vol. 113, pp. 102492-102492
Open Access | Times Cited: 9

Showing 9 citing articles:

Molecular mechanisms of tumor resistance to radiotherapy
Yu Wu, Yingqiu Song, Runze Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 194
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 13
Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin
Tianyi Gao, Stefania Magnano, Amy Rynne, et al.
Experimental Cell Research (2024) Vol. 437, Iss. 1, pp. 113995-113995
Open Access | Times Cited: 4
Evasion of apoptosis and treatment resistance in squamous cell carcinoma of the head and neck
Ben O’Leary, Heath D. Skinner, Jonathan D. Schoenfeld, et al.
Cancer Treatment Reviews (2024) Vol. 129, pp. 102773-102773
Open Access | Times Cited: 4
Targeting Inhibitor of Apoptosis Proteins to Overcome Chemotherapy Resistance—A Marriage between Targeted Therapy and Cytotoxic Chemotherapy
Tiago Barroso, Cecília Melo-Alvim, Leonor Ribeiro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13385-13385
Open Access | Times Cited: 5
Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas
Chester Gauss, Logan D. Stone, Mehrnoosh Ghafouri, et al.
Cells (2024) Vol. 13, Iss. 12, pp. 1018-1018
Open Access | Times Cited: 1
ZNF37A downregulation promotes TNFRSF6B expression and leads to therapeutic resistance to concurrent chemoradiotherapy in rectal cancer patients
Ying Huang, Jing Jin, Ningxin Ren, et al.
Translational Oncology (2024) Vol. 51, pp. 102203-102203
Open Access | Times Cited: 1
The Effect of Xevinapant Combined with Ionizing Radiation on HNSCC and Normal Tissue Cells and the Impact of Xevinapant on Its Targeted Proteins cIAP1 and XIAP
Julia Fleischmann, Laura S. Hildebrand, Lukas Kuhlmann, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1653-1653
Open Access | Times Cited: 3
Chemotherapy Resistance in Cancer: Mechanism and Roadmap to Evade Exploring Apoptosis
Kalpataru Halder
International Journal of Advancement in Life Sciences Research (2024) Vol. 07, Iss. 02, pp. 17-40
Open Access
Page 1

Scroll to top